RESEARCH
Outcomes in Total Hip Arthroplasty After Preoperative Single-Dose Intravenous Dexamethasone Administration: A Systematic Review and Meta-Analysis of Randomized Controlled Trials .
As enhanced recovery protocols evolve, questions remain about optimizing perioperative care in total hip arthroplasty (THA). Across four randomized trials, dexamethasone consistently improved several early postoperative outcomes: pain was lower at 24 and 72 hours, opioid use over the first 72 hours was reduced, and patients went home slightly sooner. It also clearly lowered the risk of postoperative nausea and vomiting, a major source of discomfort after TKA. Importantly, no increase in wound infections was observed. Although the evidence base is small and somewhat imprecise, the overall pattern supports dexamethasone as a useful, safe adjunct that may soon be reflected in future clinical guidelines.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
